Protagenic Therapeutics, Inc.\new Deferred Federal Income Tax Expense (Benefit)
Protagenic Therapeutics, Inc.\new (PTIX) reported Deferred Federal Income Tax Expense (Benefit) of -$128.00 thousand for the 12-month period ending 2015-06-30, per its 10-K filed 2015-09-25.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2015-09-25
- Protagenic Therapeutics, Inc.\new deferred federal income tax expense (benefit) for fiscal 2015 was -$128.00K, a 128.38% decline from fiscal 2014.
- Protagenic Therapeutics, Inc.\new deferred federal income tax expense (benefit) for fiscal 2014 was $451.00K, a 28.86% increase from fiscal 2013.
- Protagenic Therapeutics, Inc.\new deferred federal income tax expense (benefit) for fiscal 2013 was $350.00K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2015-06-30 | -$128.00K 10-K · filed 2015-09-25 | |
| 2014-06-30 | $451.00K 10-K · filed 2015-09-25 | -$451.00K 10-K · filed 2014-10-14 |
| 2013-06-30 | $350.00K 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |